EP 1707238 A4 20090909 - PHARMACEUTICALS OF CHINESE TRADITIONAL MEDICINE OF TREATING LUNG CANCER AND PREPARATION METHOD THEREOF
Title (en)
PHARMACEUTICALS OF CHINESE TRADITIONAL MEDICINE OF TREATING LUNG CANCER AND PREPARATION METHOD THEREOF
Title (de)
PHARMAZEUTIKA AUS DER TRADITIONELLEN CHINESISCHEN MEDIZIN ZUR BEHANDLUNG VON LUNGENKREBS UND HERSTELLUNGSVERFAHREN DAFÜR
Title (fr)
PRODUITS PHARMACEUTIQUES ISSUS DE LA MEDECINE TRADITIONNELLE CHINOISE POUR LE TRAITEMENT DU CANCER DU POUMON ET PROCEDE POUR PREPARER LESDITS PRODUITS
Publication
Application
Priority
CN 0301098 W 20031219
Abstract (en)
[origin: US2005136132A1] The present invention provides a composition for treating cancers, which comprises (a) pharmaceutically acceptable carriers and (b) an effective amount of an aqueous or aqueous organic solvent extract of a crude preparation comprising Semen Trigonellae, Astragali Radix, Glehniae Radix, and Asparagi Radix. The preferred composition further comprises the extract of other anti-tumor medicinal materials, such as Fructus Ligustri Lucidi, or Herba Selaginellae Doederleinii. The present invention also provides the preparation method and use of the composition in treating cancers, especially lung cancers.
IPC 8 full level
A61P 35/04 (2006.01); A61K 36/10 (2006.01); A61K 36/23 (2006.01); A61K 36/296 (2006.01); A61K 36/40 (2006.01); A61K 36/424 (2006.01); A61K 36/48 (2006.01); A61K 36/481 (2006.01); A61K 36/489 (2006.01); A61K 36/537 (2006.01); A61K 36/638 (2006.01); A61K 36/748 (2006.01); A61K 36/896 (2006.01); A61K 36/8965 (2006.01); A61K 36/8968 (2006.01)
CPC (source: EP US)
A61K 36/10 (2013.01 - EP US); A61K 36/23 (2013.01 - EP US); A61K 36/296 (2013.01 - EP US); A61K 36/40 (2013.01 - EP US); A61K 36/424 (2013.01 - EP US); A61K 36/48 (2013.01 - EP US); A61K 36/481 (2013.01 - EP US); A61K 36/489 (2013.01 - EP US); A61K 36/537 (2013.01 - EP US); A61K 36/638 (2013.01 - EP US); A61K 36/748 (2013.01 - EP US); A61K 36/896 (2013.01 - EP US); A61K 36/8965 (2013.01 - EP US); A61K 36/8968 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP)
Citation (search report)
- [Y] CN 1437977 A 20030827 - XU XINLIN [CN]
- [Y] EP 0775451 A1 19970528 - VITAMED REMEDIES PRIVATE LIMIT [IN]
- [Y] CN 1178687 A 19980415 - CHI JINGHUI [CN]
- [Y] DE 3225056 A1 19840105 - KOENIG FRIEDRICH KARL DR MED
- [DY] US 4613591 A 19860923 - ABURADA MASAKI [JP], et al
- [Y] HIBASAMI HIROSHIGE ET AL: "Protodioscin isolated from fenugreek (Trigonella foenumgraecum L.) induces cell death and morphological change indicative of apoptosis in leukemic cell line H-60, but not in gastric cancer cell line KATO III", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, SPANDIDOS, ATHENS, GR, vol. 11, no. 1, 1 January 2003 (2003-01-01), pages 23 - 26, XP008103619, ISSN: 1107-3756
- [Y] DEVASENA T ET AL: "Fenugreek Affects the Activity of [beta]-glucuronidase and Mucinase in the Colon", PHYTOTHERAPY RESEARCH 200311 GB, vol. 17, no. 9, November 2003 (2003-11-01), pages 1088 - 1091, XP002538389, ISSN: 0951-418X
- See references of WO 2005058337A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2005136132 A1 20050623; US 7569234 B2 20090804; AU 2003289658 A1 20050705; CA 2546636 A1 20050630; CN 100478014 C 20090415; CN 1819836 A 20060816; EP 1707238 A1 20061004; EP 1707238 A4 20090909; JP 2007512219 A 20070517; WO 2005058337 A1 20050630
DOCDB simple family (application)
US 49803804 A 20041105; AU 2003289658 A 20031219; CA 2546636 A 20031219; CN 0301098 W 20031219; CN 200380110423 A 20031219; EP 03779658 A 20031219; JP 2005512145 A 20031219